Natus Medical Enterprise Value over EBITDA Trend

Natus Medical Incorporated -- USA Stock  

USD 39.15  0.2  0.51%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 142, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 30.0252. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Enterprise Value over EBITDA of Natus Medical Incorporated with missing and latest data points interpolated. Measures the ratio between Enterprise Value and Earnings Before Interest Taxes and Depreciation Amortization USD.
Enterprise Value over EBITDA  10 Years Trend  
Increasing
Very volatile
 Enterprise Value over EBITDA 
      Timeline 

Natus Medical Enterprise Value over EBITDA Over Time

2015-12-31  22 
2016-12-31  14.83 
2017-12-31  19.38 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean (83.15)
Geometric Mean  23.11
Coefficient Of Variation (405.04)
Mean Deviation  178.17
Median  15.72
Standard Deviation  336.8
Sample Variance  113,434
Range  1,174
R Value  0.060842
Mean Square Error  124,316
R Squared  0.003702
Significance  0.85
Slope  5.68
Total Sum of Squares  1,247,775

Currently Trending

C   
 NYQ 
Purchased over 40 shares of
1 hour ago ago
Traded for 72.11
TWTR   
 NYQ 
Purchased over 100 shares of
1 hour ago ago
Traded for 18.63
S   
 NYQ 
Purchased over 400 shares of
1 hour ago ago
Traded for 7.12